Polar Capital’s Lexicon Pharmaceuticals LXRX Stock Holding History

Polar Capital’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-30,000	Closed	-$359K	–	268
2016 Q1	$359K	Buy	30,000 +5,000	+20%	+$52.4K	0.01%	255
2015 Q4	$333K	Buy	+25,000	New	+$307K	0.01%	257

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Polar Capital's LXRX Position: Q2 2016 in Review

Polar Capital sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2016, closing a stake of 30,000 shares — an estimated $359K sold.

Polar Capital first reported a position in LXRX in Q4 2015 and held it in 2 quarters. The position peaked at $359K in Q1 2016. 138 funds tracked by Wall St. Rank hold LXRX as of Q2 2016.

Polar Capital reported no remaining Lexicon Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
Polar Capital sold 30,000 Lexicon Pharmaceuticals shares in Q2 2016, an estimated $359K.
Polar Capital first reported a position in Lexicon Pharmaceuticals in Q4 2015 and held it in 2 quarters.
Polar Capital's Lexicon Pharmaceuticals position peaked at $359K in Q1 2016.
138 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2016.

Based on Polar Capital's 13F filing for Q2 2016, filed 15 Aug 2016.